AMEXCID

AMEXCID aims to promote sustainable human development to improve the standard of living of the world’s population. In Mexico and the world, we work hand in hand with specialists and build strategic alliances with the private and academic sectors, civil society, and local governments, to coordinate, plan, and evaluate our Cooperation and Promotion efforts (educational, cultural and tourism, technical and scientific, financial, and economic). With this, we develop capabilities to contribute to sustainable human development, reduce inequality, and improve people’s quality of life.

Through AMEXCID, Mexico offers and receives development cooperation. On the one hand, we share successful experiences, strengthen capacities, and exchange human, technical, and financial resources with developing countries, particularly in Central America and the Caribbean. On the other hand, we work with strategic partners to enhance our capabilities, improve our institutions, and generate tangible results that strengthen Mexico.

AVANT-SANTÉ / ETCURAE

Avant Santé Research Center S.A. de C.V., headquartered in Monterrey, Mexico, is a distinguished Contract Research Organization (CRO) committed to revolutionizing Clinical Research by prioritizing Patient-centricity, Quality, and Deliverables. Our philosophy revolves around integrity, honesty, and transparency, instilling trust and confidence among our clients, partners, and study participants. We foster collaborative relationships with sponsors, investigators, regulatory authorities, and patient communities to collectively propel medical science forward.
Offering a comprehensive spectrum of services, Avant Santé specializes in everything from Early Phase I first-in-human studies to regulatory services.
Our Phase I facility in Monterrey features 80 beds dedicated to healthy human BA/BE studies and 16 beds for early Phase 1 first-in-human studies. This state-of-the-art facility is particularly expert at conducting patient PD studies in asthma patients (methacholine challenge), early Phase 1 first-in-human studies, and healthy human BA/BE studies, adhering to the standards of USFDA, EMA, ANVISA, COFEPRIS, LATAM, and TGA.
Avant Santé also provides LATAM regulatory services through its subsidiary, Udela Global, offering a range of services including product dossier preparation, attendance at new molecule committee meetings, facilitation of technical meetings with regulatory agencies, and acting as sponsors’ representatives during interactions with regulatory bodies
Avant Santé plays a significant role in late-phase clinical trials (Phase II to IV) focusing on metabolic and liver disorders such as obesity, T2DM, dyslipidemia, MAFLD/MASH, cirrhosis, alcohol hepatitis, PBC, PCOS, HCC, and autoimmune hepatitis. With a site network spanning five LATAM countries and encompassing over 100 sites, we are positioned to make substantial progress in the field of clinical research. Avant Santé also has collaboration with public institutions in Mexico through its Subsidiary EtCurae® for an exclusive access of patient population.

INCIDE

The Innovation and Science Foundation for Business Development INCIDE, is a non-profit organization, founded in 2013 by an agreement between a group of 100% Mexican companies committed to technological development and innovation.

CECYPE

CECYPE is your ally in Biologics and Biosimilars clinical trials. Since 1995, we have been a COFEPRIS (Mexican Regulatory Agency) authorized third party for conducting clinical trials. We are also an industry leader in México, providing innovative and reliable products and support to our clients. CECYPE is specialized in Phase I healthy volunteer clinical trials. Our team of experts is dedicated to helping our clients move their drugs to the next development step faster without sacrificing quality. Our geographic location allows us to offer you competitive pricing without compromising the excellence you expect and deserve.

We offer a range of other complimentary services for clinical trials that include: Biologic/Biosimilar trials, Vaccine trials, Tailored analytical assays for PK and ADAs, Pharmacodynamics, Hospital alliances for trials with patients, Bridging studies, Ethics and research committees, Preclinical trials and more.

CECYPE, is not just a CRO; It’s a dedicated partner with a long-standing record of success. We have the expertise, the facilities, and the passion to ensure your biologic/biosimilar trials are conducted with the utmost care, precision and strict adherence to good clinical practices.

EPIC-CRO

We are focused on providing a full range of tailored, efficient, high-quality, and cost-effective clinical development, regulatory, and post-approval services to the Pharmaceutical, Biotech, Medical Device, and Nutriceutical industries.

At EPIC, we help develop and bring new molecules and developments to the regulatory process through trial design, management, site selections, CRFs, ICF, and other material developments emphasizing collaborative work with your team and our clinical and regulatory experts to ensure cost-effective results.

GRUPOT ITRASIG

This group of companies is currently the preponderant biotechnology cluster in molecular diagnostics in Mexico and Latin America, we are the most important actor in the innovation and manufacturing of artificial DNA and genetic diagnostics in Mexico and Latin America, exporting quality and certified products to various parts of the world.

IPN

We are an educational institution in Mexico dedicated to technological education. Our mission is to cultivate professionals, researchers, and innovators who contribute to the social, humanistic, sustainable, economic, and technological development of our country. Our objective is to gain international recognition by fostering a culture of creativity, entrepreneurship, and innovation among our students. We prioritize building strong partnerships with the business and social sectors while upholding our institutional values and principles.
By 2036, we envision ourselves as a high-quality technological education institution, characterized by a focus on sustainability, a strong sense of identity, and international recognition. We strive to be among the top universities in the world, achieved through international collaboration with leading schools and research centers. Our leadership will be defined by our contributions to science and technology, making a meaningful impact while upholding a sense of social responsibility. We value diversity and gender equity, fostering an inclusive environment for all.

LIOMONT

It was established in 1938 and has grown to be one of the top pharmaceutical companies in Mexico. Their products are commercialized in most of Latin America, the U.S., and Europe. They develop and commercialize small molecule drugs as well as biopharmaceuticals and vaccines. In 2020, the company entered into an agreement with AstraZeneca to produce their Covid Vaccine for Latin America. As of today, they have manufactured almost 100 million doses of this vaccine.

The company is looking to out-license our biosimilar products and is also looking for partners with assets that can strengthen its portfolio. Additionally, they seek to establish partnerships with biotech or vaccine companies that might be interested in manufacturing their products in their state-of-the-art facility where they have a capacity for both cell culture and aseptic filling of vials.

NEW GENESIS

New Genesis (www.newgenesis.cl) is a business consultancy with 18 years of experience, founded in Chile. We have extensive expertise across Latin America, USA, and the EU, with offices in Santiago de Chile and Mexico City. Our focus is on providing innovation management services and comprehensive technology transfer process development for private companies, institutions, and startups. We develop customized services tailored to the specific requirements and objectives of each of our clients for value generation and/or capture. Our offerings include IP and Market Assessments, Identification, Evaluation, and Valuation of Technologies, Startups, and Science-Based Companies. We also specialize in structuring and implementing capital raising processes, as well as managing projects for scaling and business consolidation, where the specific application of a technology is the focus of development. Additionally, we offer services in the design, implementation, and management of acceleration projects for R&D initiatives and startups. Finally, we have +10 years of real and successful experience in managing venture capital funds and investments in technological developments. Our motto is: “Turning ideas into great projects, aiming to generate extraordinary results.”

PISA FARMACÉUTICA

PiSA Farmacéutica is a 100% Mexican company, with 77 years of history in developing comprehensive products and services for the public and private health segments in Mexico, the United States, Latin America, and the Caribbean.

For more than seven decades, growth at PiSA® Farmacéutica has been a constant thanks to its human capital. We are committed to excellence, aware that each of our actions and activities are to fulfill our reason for being: “A Life at the Service of Life.”

At PiSA® Farmacéutica we distinguish ourselves for our production capacity and extensive experience in the Mexican and Latin American market; this has allowed us to set the tone for our growth and international expansion.

PRAGMATEC

Our purpose is to promote technological development and innovation as well as connect with the best partners between México and the world in the Life Science sector. We have carried out activities for organizations from different countries such as the United Kingdom, Canada, Chile, Spain, the Netherlands, and South Korea. We can offer you strategic relationships for these specific goals:
• HealthTech Landscape Reports in the region.

• Scouting of new technologies for your open innovation strategies (researchers or startups).

• Matchmaking with potential partners such as universities, research centers, clinical trials offices, manufacturing companies, or specialized chambers of commerce.

• Connections with regulatory experts to introduce new products in this market.

• Exploratory interviews with potential customers (B2B/B2C).

• First connections with federal and local governments for nearshoring strategies in Mexico.

REDOTT

The Network of Technology Transfer Offices in Mexico (OTT Network) was conceptualized and integrated into the OTT/CEPAT of the Northwest Biological Research Center, SC in 2012 as an inclusive project made up of Public and Private Education Institutions, companies, and government.
The purpose of its creation was to strengthen the innovation ecosystem, share efforts, and collaborate in actions of common interest for the development and consolidation of the technology transfer and commercialization function, making visible the technological offer of Higher Research Institutions (IES). They seek to complement experiences in training and mobility, success stories, monitoring of activity measurement indicators, and possibilities for developing technologies among HEIs to optimize economies of scale and create a culture regarding intellectual property.

PRAGMATEC

Our purpose is to promote technological development and innovation as well as connect with the best partners between México and the world in the Life Science sector. We have carried out these activities for organizations from different countries such as United Kingdom, Canada, Chile, Spain, Netherlands, and South Korea. 

We can offer you strategic relationships in these specific goals:  

– HealthTech Landscape Reports in the region.  

– Scoutting of new technologies for your Open innovation strategies (researchers or startups).  

– Matchmaking with potential partners such as universities, research centers, clinical trials offices, manufacturing companies, or specialized chambers of commerce.  

– Connections with regulatory experts to introduce new products in this market.  

– Exploratory interviews with potential customers (B2B/B2C).  

– Firsts connections with federal and local governments for nearshoring strategies in Mexico. 

TIJUANA EDC

UDELÁ

Is a Mexican company that caters to businesses entering the Latin American (LATAM) market with pharmaceuticals, medical devices, and other healthcare products. Udelá Global offers consulting services to help companies navigate the regulatory landscape for registering and marketing their products in LATAM countries. They can act as your legal representative in LATAM, simplifying the legal aspects of doing business in the region. Also provides warehousing and distribution solutions specifically designed for the pharmaceutical and healthcare industry.
Udelá Global offers a comprehensive service package, or clients can choose specific services needed:

• Regulatory consulting and strategy development for market entry in LATAM.

• Legal representation to navigate legalities and ensure compliance.

• Warehousing and distribution solutions tailored for healthcare products.

Tijuana EDC

UDIBI

UDIBI is a spin off company of the National Polytechnic Institute of Mexico. It is managed by 10 qualified scientists and +70 supporting personnel specializing in a variety of services for the pharmaceutical, medical device and biotechnology industries, including drug discovery, non-clinical studies, protein manufacturing, and consulting in regulatory affairs. UDIBI is an authorized third-party laboratory of the Mexican Ministry of Health (COFEPRIS) and is also part of the National Laboratories network of the National Council of Humanities, Sciences and Technologies of Mexico (CONAHCYT). In collaboration with GlobalBio, Inc., UDIBI established a state-of-the-art platform for the discovery, optimization, and production of antibodies, peptides, and proteins for diagnostic and therapeutic applications. UDIBI’s portfolio includes an immunomodulator medicine patented in 39 countries with sales of $20 MN USD a year, a diagnostic kit for measuring anti-SARS-CoV2 antibodies, five therapeutics antibodies at different development stages, and over 20 recombinant proteins and antibodies available on sale for research and diagnostic applications.

ORGANON

At Organon, we are committed to being your partner of choice for Contract Manufacturing Operations. We bring unmatched quality, service and flexibility through our legacy of developing standards in manufacturing, packaging, and distribution. Organon’s customers are assured of quality in manufacturing, packaging, testing and warehousing. We have a strong focus on sustainability, incorporating eco-friendly practices to minimize our carbon footprint in all our operations.

Our manufacturing facility, located south of Mexico City, provides capabilities in Oral Solid Dosage manufacturing and Primary/Secondary packaging, allowing great flexibility in logistics, whether by land, sea, or air. We supply more than 30 countries, including North and Latin America and others around the world. The facility has the installed capacity to produce more than 50 million packs annually and satisfy the demand of potential partners.

Our Plant stands as a testament to our commitment to excellence, innovation and continuing improvement for our customers. Our state-of-the-art equipment and highly skilled professionals ensure every product meets and exceeds industry benchmarks.